8-K

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934



         Date of Report (Date of earliest event reported): April 3, 2007


                        Blonder Tongue Laboratories, Inc.
             (Exact Name of registrant as specified in its charter)



           Delaware                        1-14120                  52-1611421
(State or other jurisdiction     (Commission File Number)      (I.R.S. Employer
      of incorporation)                                      Identification No.)


                One Jake Brown Road, Old Bridge, New Jersey 08857
               (Address of principal executive offices) (Zip Code)



       Registrant's telephone number, including area code: (732) 679-4000


                                 Not Applicable
          (Former name or former address, if changed since last report)


Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:


[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)


[_]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)


[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d-2(b))


[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))






Item 2.02.  Results of Operations and Financial Condition

On April 3, 2007,  Blonder  Tongue  Laboratories,  Inc.  issued a press  release
announcing its financial  results for the fourth quarter and year ended December
31, 2006. A copy of the press release is attached to this Report as Exhibit 99.1
and is  incorporated  herein by  reference.  The  information  disclosed in this
report,  including  Exhibit 99.1  hereto,  is being  furnished  and shall not be
deemed  "filed" for  purposes of Section 18 of the  Securities  Exchange  Act of
1934.

Item 9.01.  Financial Statements and Exhibits

(a)      Not applicable


(b)      Not applicable


(c)      Not applicable


(d)      The following exhibits are filed herewith:


     Exhibit 99.1 Press Release dated April 3, 2007.







                                       2


                                    SIGNATURE


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                    BLONDER TONGUE LABORATORIES, INC.



                                    By:  /s/ Eric Skolnik
                                         Eric Skolnik
                                         Senior Vice President
                                         and Chief Financial Officer

Date: April 3, 2007







                                       3







                                  EXHIBIT INDEX


Exhibit No.               Description

Exhibit 99.1     Press Release of Blonder Tongue Laboratories, Inc. dated April
                 3, 2007  regarding its financial results for the fourth quarter
                 and year ended December 31, 2006.







                                       4

EX-99

                                                                    EXHIBIT 99.1


[LOGO]
                                                             One Jake Brown Road
                                                                   P.O. Box 1000
                                                       Old Bridge, NJ 08857-1000
                                               (732) 679-4000 Fax (732) 679-4353
                                                           www.blondertongue.com




FOR IMMEDIATE RELEASE                   CONTACT:                 James A. Luksch
                                                                    Chairman and
                                                         Chief Executive Officer
                                                                  (732) 679-4000

                  BLONDER TONGUE REPORTS 2006 YEAR END RESULTS

OLD BRIDGE, NEW JERSEY, April 3, 2007 - Blonder Tongue Laboratories, Inc. (AMEX:
"BDR") today reported net sales of  $35,775,000  for the year ended December 31,
2006, a three percent (3%) increase over net sales of  $34,730,000  reported for
the year  ended  December  31,  2005.  The  increase  in net sales is  primarily
attributed to increased sales of digital  headend and fiber products,  offset by
decreased sales of  interdiction  and analog headend  products.  Digital headend
sales  were  $5,715,000  and   $4,725,000,   fiber  sales  were  $1,731,000  and
$1,027,000, interdiction sales were $1,835,000 and $2,054,000 and analog headend
sales were $17,506,000 and $17,901,000 in 2006 and 2005, respectively.

Loss from continuing  operations  after income taxes was $ 96,000 or $(0.01) per
share for the year ended  December 31, 2006 as compared to $4,956,000 or $(0.62)
per share,  for the comparable  period in 2005. Net income was $342,000 or $0.05
per share in 2006 as compared to a net loss of  $5,500,000  or $(0.69) per share
for the comparable period in 2005.

Commenting  on the year end 2006  results,  James  A.  Luksch,  Chief  Executive
Officer, said, "2006 was a year of consolidation and refocus of our attention to
core market needs,  as  contemplated  by our strategic  plan. In response to the
ongoing transition from analog to digital transmission of video signals, we have
added  several new  products to our digital  product  offerings  and continue to
evaluate additional new digital product opportunities. The results are increased
sales,  reduced debt and  corresponding  interest  expense and  increased  gross
margin. Our initiative in China is on course and gaining momentum,  which should
produce  noticeable  benefits in the second  half of 2007 and  increase in later
time periods."

Founded  in  1950,  Blonder  Tongue  Laboratories,   Inc.  has  evolved  from  a
manufacturer  of  electronic  equipment  for the  private  cable  industry  to a
principal  provider of integrated  network  solutions and technical  services to
broadband  service  providers  in  the  multiple  dwelling  unit,   lodging  and
hospitality, and institutional cable markets. The Company designs, manufactures,
and  supplies a  comprehensive  line of  equipment  to deliver  video  (analog &
digital),  high speed data and voice services over integrated  coaxial and fiber
optic broadband networks today and over packet based, Internet protocol networks
of the future.  For more information  regarding  Blonder Tongue or its products,
please  visit the  Company's  Web site at  www.blondertongue.com  or contact the
Company directly at (732) 679-4000.

"Safe Harbor"  Statement under the Private  Securities  Litigation Reform Act of
1995: The information set forth above includes "forward-looking"  statements and
accordingly,  the cautionary  statements  contained in Blonder  Tongue's  Annual
Report and Form 10-K for the year ended December 31, 2006 (See Item 1: Business,
Item 1A:  Risk  Factors  and Item 7:  Management's  Discussion  and  Analysis of
Financial  Condition  and Results of  Operations),  and other  filings  with the
Securities and Exchange  Commission are  incorporated  herein by reference.  The
words  "believe",  "expect",  "anticipate",  "should",  "project",  and  similar
expressions identify  forward-looking  statements.  Readers are cautioned not to
place  undue  reliance  on  these  forward-looking  statements,   which  reflect
management's  analysis only as of the date hereof.  Blonder Tongue undertakes no
obligation to publicly revise these forward-looking statements to reflect events
or  circumstances  that arise after the date  hereof.  Blonder  Tongue's  actual
results may differ from the anticipated results or other expectations  expressed
in Blonder Tongue's "forward-looking" statements 

                                     -MORE-




                        Blonder Tongue Laboratories, Inc.
                    Consolidated Summary of Operating Results
                      (in thousands, except per-share data)



                                                       Year ended
                                                      December 31,
                                               ----------------------------
                                                   2006           2005

Net sales                                          $35,775        $34,730
Gross profit                                        12,366          7,331
Earnings (loss) from operations                        336         (3,724)
Loss from continuing operations                        (96)        (4,956)
Loss from discontinued operations (net of
tax)                                                  (500)          (544)
Gain on disposal of subsidiary                         938              -
Net income (loss)                                     $342        $(5,500)
Basic and diluted loss per share from
continuing operations                               $(0.01)        $(0.62)
Basic and diluted loss per share from
discontinued operations                             $(0.06)        $(0.07)
Basic and diluted gain per share on disposal         $0.12             -
Basic and diluted net income (loss) per
share                                                $0.05         $(0.69)
Basic and diluted weighted average shares
outstanding:                                         7,592          8,015






                       Consolidated Summary Balance Sheets
                                 (in thousands)


                                       December 31, 2006     December 31, 2005


Current assets                               $14,942               $15,144
Property, plant, and equipment, net            4,537                 6,184
Total assets                                  27,222                32,864
Current liabilities                            5,431                 8,036
Long-term liabilities                          1,559                 3,329
Stockholders' equity                          20,232                21,499

Total liabilities and
stockholders' equity                         $27,222               $32,864



                                       2